Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A More Severe Non-melanoma Skin Cancer Phenotype Is Seen in Patients with Inflammatory Bowel Disease on Tumor Necrosis Factor-α Antagonists.

Digestive diseases and sciences - 1 Dec 2021

Townsend Cassandra M, Khanna Reena, Wilson Aze Suzanne

Abstract excerpt

BACKGROUND: Limited data suggest that non-melanoma skin cancer (NMSC) risk is higher in patients with inflammatory bowel disease (IBD) particularly in those on a tumor necrosis factor-α antagonist (TNF antagonist). It remains unknown whether TNF antagonist exposure alters the clinical course of NMSC in patients with IBD or if this therapy should be discontinued. AIMS: To assess the impact of TNF antagonist...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Inflammatory Bowel Diseases
Share to Neoplasm Recurrence, Local

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to Skin Neoplasms

Source

Identifiers

PMID: 33428042
DOI: 10.1007/s10620-020-06773-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A More Severe Non-melanoma Skin Cancer Phenotype Is Seen in Patients with Inflammatory Bowel Disease on Tumor Necrosis Factor-α Antagonists.PMID 33428042Read ↗

Inflammatory bowel disease, cancer and medication: Cancer risk in the Dutch population-based IBDSL cohort.Semantic proximity Read ↗

Characteristics of Skin Lesions Associated With Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease: A Cohort Study.Semantic proximity Read ↗

Case Report: Malignant melanoma in a patient with Crohn’s disease treated with ustekinumabSemantic proximity Read ↗

Inflammatory Bowel Disease Risk Variants Are Associated with an Increased Risk of Skin CancerSemantic proximity Read ↗

Dermatologic disease in Inflammatory Bowel Disease: a 10-year, 401-patient cohort from a dedicated IBD– Dermatology ProgramSemantic proximity Read ↗

Colonic Phenotypes Are Associated with Poorer Response to Anti-TNF Therapies in Patients with IBD.Semantic proximity Read ↗

Frequency, phenotype, outcome, and therapeutic impact of skin reactions following initiation of adalimumab therapy: experience from a consecutive cohort of inflammatory bowel disease patients.Semantic proximity Read ↗

Does a personal or family history of malignancy preclude the use of immunomodulators and biologics in IBD.Semantic proximity Read ↗

The Oncology: Disease Modifying Anti-Rheumatic Drug Interface: A Cross-Specialty ReviewSemantic proximity Read ↗

Severe colitis in patients with melanoma treated with BRAF/MEK inhibitors.Semantic proximity Read ↗

Association of Antibiotic Exposure With Survival and Toxicity in Patients With Melanoma Receiving Immunotherapy.Semantic proximity Read ↗

Impact of medical therapy on patients with Crohn's disease requiring surgical resection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.